# Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes

> **NCT00493571** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 16 (actual)

## Conditions studied

- Myelodysplastic Syndromes
- MDS

## Interventions

- **DRUG:** Gimatecan

## Key facts

- **NCT ID:** NCT00493571
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00493571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00493571, "Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00493571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*